Holdings
36
Concentrated
Top 10 weight
57%
Concentration
Strategy
Active
Portfolio style
Equity
96%
Asset allocation
Portfolio
4Sectors6Large positions64.5%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap42%
Mid cap22%
Small cap32%
Asset allocation
Equity96%
Top holdings
Apollo Hospitals Enterprise LimitedEQUITY8.7%
Sun Pharmaceutical Industries LimitedEQUITY8.7%
Cipla LimitedEQUITY6.7%
Divi's Laboratories LimitedEQUITY6.4%
Max Healthcare Institute LimitedEQUITY6.3%
Dr. Reddy's Laboratories LimitedEQUITY5.0%
JB Chemicals & Pharmaceuticals LimitedEQUITY4.5%
Triparty Repo TRP_010626OTHER4.0%
Glenmark Pharmaceuticals LimitedEQUITY3.6%
Dr. Lal Path Labs LimitedEQUITY3.0%
Sign in for free to unlock all 36 holdings →Portfolio insights
Portfolio read
- 96% equity.
- Large-cap exposure is 42%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 64.5%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 64%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in this category.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services28.9%
Insurance2.4%
IT - Services0.3%